EXPD vs QNCX · P/E 26, rev $6.29B vs $79.3M cap
Expeditors International of Washington, Inc. (EXPD) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
QNCX does not have a complete income-statement cache yet.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. QNCX currently screens at market cap $79.3M.
Not investment advice. Open the EXPD and QNCX stock pages for the full models.
Not investment advice.